Cardiovascular Diseases Research in Louisiana
Cardiovascular Diseases Research (93.837) awarded $93.7 million to recipients in Louisiana in 85 grants from fiscal 2021 to 2025, 0.6% of the program's national total. The Administrators of Tulane Educational Fund received the most, $51.5 million.
- Awarded in Louisiana$93.7 million
- Awards85
- Share of the program0.6%
- Rank among states28th of 51
- National total$15 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 40 | $17.0 million |
| FY 2022 | 48 | $21.4 million |
| FY 2023 | 43 | $18.3 million |
| FY 2024 | 42 | $17.8 million |
| FY 2025 | 45 | $19.4 million |
Recipients in Louisiana
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| The Administrators of Tulane Educational Fund | Colleges and universities | 43 | $51.5 million |
| Louisiana State University | Colleges and universities | 21 | $20.7 million |
| Louisiana State University Health Sciences Center New Orleans | Colleges and universities | 13 | $16.0 million |
| Pennington Biomedical Research Center | Colleges and universities | 3 | $2.7 million |
| Louisiana State University Agricultural Center | Colleges and universities | 1 | $1.7 million |
| Louisiana State University | Colleges and universities | 2 | $535,552 |
| Refined Imaging, LLC | Small businesses | 1 | $377,996 |
| Levisonics Inc | Small businesses | 1 | $299,309 |
Open opportunities under this program
- Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)
- Emerging Global Leader Award (K43 Independent Clinical Trial Required)
- NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
- Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
- NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)
- NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required)
- Continuation of the Cardiovascular Repository for-Type 1 Diabetes (CARE-T1D) Consortium U01 (Open Competition)- Research (U01, Clinical Trial Not Allowed)
- NHLBI Clinical Trial Pilot Studies (R34 Clinical Trial Optional)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
See all 81 on the program page
Questions people ask
How much Cardiovascular Diseases Research money goes to Louisiana?
$93.7 million from fiscal 2021 to 2025, across 85 awards. Louisiana ranks 28th of 51 states and territories for this program.
Who receives Cardiovascular Diseases Research money in Louisiana?
The largest recipient is The Administrators of Tulane Educational Fund, with $51.5 million in 43 awards. Next are Louisiana State University and Louisiana State University Health Sciences Center New Orleans.
Can organizations in Louisiana apply now?
Yes, 81 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Cardiovascular Diseases Research in other states
Other large programs in Louisiana
- Grants to States for Medicaid
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)
- Highway Planning and Construction
- Education Stabilization Fund
- Community Development Block Grants/State's program and Non-Entitlement Grants in Hawaii
- National School Lunch Program
- Children's Health Insurance Program
- Title I Grants to Local Educational Agencies
- Child Care and Development Block Grant
- Broadband Equity, Access, and Deployment Program